Sang‐Ging Ong

2.2k citations

41 papers · 1.4k indexed · h-index 20

Impact in

Aging top 10%
Cardiology and Cardiovascular Medicine top 5%
- Chemotherapy-induced cardiotoxicity and mitigation

Papers in ⓘ

Cancer Research 10
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 4
Clinical Biochemistry 3
- Metabolism and Genetic Disorders 3

Co-authors: Derek J. Hausenloy (8 shared papers)Joseph C. Wu (9 shared papers)Sang‐Bing Ong (9 shared papers)Won Hee Lee (9 shared papers)Nur Izzah Ismail (3 shared papers)Lei Tian (2 shared papers)Sauri Hernández‐Reséndiz (3 shared papers)Siavash Beikoghli Kalkhoran (2 shared papers)
Journals: Nature Communications (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Journal of Clinical Investigation (2 papers)PLoS Biology (2 papers)Pharmacology & Therapeutics (2 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Sang‐Ging Ong

40 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sang‐Ging Ong

Since Specialization

Citations

This map shows the geographic impact of Sang‐Ging Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Ging Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Ging Ong more than expected).

Fields of papers citing papers by Sang‐Ging Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Ging Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Ging Ong. The network helps show where Sang‐Ging Ong may publish in the future.

Co-authors

The 25 scholars most cited alongside Sang‐Ging Ong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sang‐Ging Ong Line = papers co-authored together Sang‐Ging Ong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer Circulation ·Tomoya Kitani, Sang‐Ging Ong, Chi Keung Lam, June‐Wha Rhee, Joe Z. Zhang, Angelos Oikonomopoulos, Nan Ma, Lei Tian, Jaecheol Lee, Melinda L. Telli, Ronald Witteles, Arun Sharma, Nazish Sayed, Joseph C. Wu	2019	148
2	Modeling Cardiovascular Risks of E-Cigarettes With Human-Induced Pluripotent Stem Cell–Derived Endothelial Cells Journal of the American College of Cardiology ·Won Hee Lee, Sang‐Ging Ong, Yang Zhou, Lei Tian, Hye Ryeong Bae, Natalie Baker, Adam Whitlatch, Leila Mohammadi, Hongchao Guo, Kari C. Nadeau, Matthew L. Springer, Suzaynn F. Schick, Aruni Bhatnagar, Joseph C. Wu	2019	107
3	A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope PLoS Biology ·Ziying Hu, Shuai Wang, Chengdong Zhang, Ning Gao, Miaomiao Li, Deqian Wang, Daqi Wang, Dong Liu, Huihui Liu, Sang‐Ging Ong, Hongyan Wang, Yongming Wang	2020	106
4	Hypoxia-inducible factor as a therapeutic target for cardioprotection Pharmacology & Therapeutics ·Sang‐Ging Ong, Derek J. Hausenloy	2012	96
5	Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore American Journal of Physiology-Heart and Circulatory Physiology ·Christopher Smith, Richard A. F. Dixon, Abigail Wynne, Louise Theodorou, Sang‐Ging Ong, Sapna Subrayan, Sean M. Davidson, Derek J. Hausenloy, Derek M. Yellon	2010	92
6	Effect of Human Donor Cell Source on Differentiation and Function of Cardiac Induced Pluripotent Stem Cells Journal of the American College of Cardiology ·Verónica Sánchez-Freire, Andrew S. Lee, Shijun Hu, Oscar J. Abilez, Ping Liang, Feng Lan, Bruno Hüber, Sang‐Ging Ong, Wan Xing Hong, Mei Huang, Joseph C. Wu	2014	91
7	Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury Expert Opinion on Therapeutic Targets ·Sang‐Bing Ong, Khairunnisa Katwadi, Xiu-Yi Kwek, Nur Izzah Ismail, Kroekkiat Chinda, Sang‐Ging Ong, Derek J. Hausenloy	2018	87
8	Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It! Cardiovascular Drugs and Therapy ·Sang‐Bing Ong, Siavash Beikoghli Kalkhoran, Sauri Hernández‐Reséndiz, Parisa Samangouei, Sang‐Ging Ong, Derek J. Hausenloy	2017	85
9	Development of Poly(β-amino ester)-Based Biodegradable Nanoparticles for Nonviral Delivery of Minicircle DNA ACS Nano ·Michael Keeney, Sang‐Ging Ong, Amanda Padilla, Zhenyu Yao, Stuart B. Goodman, Joseph C. Wu, Fan Yang	2013	71
10	Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy Proceedings of the National Academy of Sciences ·Alex Chia Yu Chang, Sang‐Ging Ong, Edward L. LaGory, Peggy E. Kraft, Amato J. Giaccia, Joseph C. Wu, Helen M. Blau	2016	56
11	Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection Pharmacology & Therapeutics ·Uma Mukherjee, Sang‐Bing Ong, Sang‐Ging Ong, Derek J. Hausenloy	2015	54
12	Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxidants and Redox Signaling ·Xing Chang, Nur Izzah Ismail, Attaur Rahman, Dachun Xu, Renee W. Y. Chan, Sang‐Ging Ong, Sang‐Bing Ong	2022	37
13	miR-21 is associated with fibrosis and right ventricular failure JCI Insight ·Sushma Reddy, Dong‐Qing Hu, Mingming Zhao, Eddie Blay, Nefthi Sandeep, Sang‐Ging Ong, Gwanghyun Jung, Kristina B. Kooiker, Michael Coronado, Giovanni Fajardo, Daniel Bernstein	2017	33
14	Allogeneic Mesenchymal Stromal Cells Overexpressing Mutant Human Hypoxia‐Inducible Factor 1‐α (HIF1‐α) in an Ovine Model of Acute Myocardial Infarction Journal of the American Heart Association ·Anna P. Hnatiuk, Sang‐Ging Ong, Fernanda Daniela Olea, Paola Locatelli, Johannes Riegler, Won Hee Lee, Cheng Hao Jen, Andrea De Lorenzi, Carlos Sebastián Giménez, R Laguens, Joseph C. Wu, Alberto Crottogini	2016	32
15	Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation Stem Cell Reports ·Liang Hong, Meihong Zhang, Olivia T Ly, Hanna Chen, Arvind Sridhar, Erin Lambers, Brandon Chalazan, Seock‐Won Youn, Mark Maienschein‐Cline, Leonid Feferman, Sang‐Ging Ong, Joseph C. Wu, Jalees Rehman, Dawood Darbar	2021	29
16	Progenitor-like characteristics in a subgroup of UCP1+ cells within white adipose tissue Developmental Cell ·Jooman Park, Sunhye Shin, Lifeng Liu, Iffat Jahan, Sang‐Ging Ong, Pingwen Xu, Daniel C. Berry, Yuwei Jiang	2021	28
17	Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology Cell & Bioscience ·Sarath Babu Nukala, Jordan Jousma, Yoonje Cho, Won Hee Lee, Sang‐Ging Ong	2022	25
18	krCRISPR: an easy and efficient strategy for generating conditional knockout of essential genes in cells Journal of Biological Engineering ·Bei Wang, Zishi Wang, Daqi Wang, Baolong Zhang, Sang‐Ging Ong, Ming‐Qing Li, Wenqiang Yu, Yongming Wang	2019	23
19	Prediction of base editor off-targets by deep learning Nature Communications ·Chengdong Zhang, Yuan Yang, Tao Qi, Yuening Zhang, Linghui Hou, Jingjing Wei, Jingcheng Yang, Leming Shi, Sang‐Ging Ong, Hongyan Wang, Hui Wang, Bo Yu, Yongming Wang	2023	21
20	Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC–derived atrial fibrillation model JCI Insight ·Olivia T Ly, Hanna Chen, Grace E. Brown, Liang Hong, Xinge Wang, Yong Duk Han, Mahmud Arif Pavel, Arvind Sridhar, Mark Maienschein‐Cline, Brandon Chalazan, Sang‐Ging Ong, Khaled Abdelhady, Malek G. Massad, Lona Ernst Rizkallah, Jalees Rehman, Salman R. Khetani, Dawood Darbar	2022	19

About Sang‐Ging Ong

Sang‐Ging Ong is a scholar working on Cancer Research, Clinical Biochemistry, Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Adipose Tissue and Metabolism (7 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), CRISPR and Genetic Engineering (5 papers), MicroRNA in disease regulation (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Aging (32 citations), Cardiology and Cardiovascular Medicine (320 citations), Cancer Research (184 citations), Molecular Biology (829 citations) and Physiology (242 citations). Sang‐Ging Ong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Derek J. Hausenloy, Joseph C. Wu, Sang‐Bing Ong, Won Hee Lee, Nur Izzah Ismail, Lei Tian, Sauri Hernández‐Reséndiz, Siavash Beikoghli Kalkhoran, Yongming Wang and Uma Mukherjee. Their work appears in journals such as Nature Communications, Frontiers in Cell and Developmental Biology, Journal of Clinical Investigation, PLoS Biology and Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact